Aerpio Therapeutics competitorsClear all
Aerpio Therapeutics's top competitors include Transgene, DBV Technologies, Synthace and Cord Blood America.
| Save Comparison |  Aerpio Therapeutics Aerpio Therapeutics, abiotechnology company,develops new small molecules and monoclonal antibodies for the treatment of vascular disease. |  Transgene Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. |  DBV Technologies We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments. | ||
Founding Date | Founding Date 2011 | Founding Date N/A | Founding Date 2002 | Founding Date 2011 | Founding Date 1999 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Blue Ash, US HQ | Locations Illkirch, FR HQ Shanghai, CN Lyon, FR Boston, US | Locations Montrouge, FR HQ Bagneux, FR New York, US Summit, US | Locations London, GB HQ Cambridge, US | Locations Las Vegas, US HQ |
Employees | Employees N/A | Employees 1392% increase | Employees 311 | Employees 77 | Employees 847% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 248 m | Valuation ($) 730 m | Valuation ($) N/A | Valuation ($) 9.9 m |
Twitter followers | Twitter followers N/A | Twitter followers 1.4 k | Twitter followers 1.6 k | Twitter followers 1.6 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 5 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 20 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2.2 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.4 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 60% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 70% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 299244 | Alexa Website Rank 221574 | Alexa Website Rank 292854 | Alexa Website Rank 523161 | Alexa Website Rank N/A |
Employee Rating | Employee Rating N/A | Employee Rating 4.4 | Employee Rating 3.4 | Employee Rating N/A | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €13.1m (FY, 2019) | Revenue (est.) £581 (FY, 2013) | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income (€153.6m) (FY, 2019) | Net income (£361.6k) (FY, 2013) | Net income ($36.8k) (FY, 2019) |
Funding | |||||
Latest funding round | Latest funding round $ 4.5m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 25.6m (about 2 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 67.5m | Total funding raised N/A | Total funding raised $ 28.2m | Total funding raised $ 41.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Transgene
HQ
Illkirch, FR
Employees
139↑ 2% increase
Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases.
View companyDBV Technologies
HQ
Montrouge, FR
Employees
311
We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.
View company
Synthace
HQ
London, GB
Employees
77
Synthace produces bio-based chemical products through the application of synthetic biology.
View company
Cord Blood America
HQ
Las Vegas, US
Employees
8↓ 47% decrease
Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.
View company